Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
ALFUZOSIN
Uroxatral, Xatral
Neurogenic Urinary Bladder
EFC5722ALPHACHINNCT00549939Tabulated Results
ALFUZOSIN
Uroxatral, Xatral
Benign Prostatic Hyperplasia
EFC5791NANCT00399464Summary
ALFUZOSIN
Uroxatral, Xatral
Hydronephosis Neurogenic Bladder
EFC6269ALPHAHYDRONCT00576823Tabulated Results
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_8472ALF-ACUTENCT00540891Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_8758NANCT00637715Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_8819NANCT00542165Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_8935ALEX-XLNCT00575913Summary
ALFUZOSIN
Uroxatral, Xatral
Urologic Diseases
L_9397ALF-RIKNCT00453908Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_9645NANCT00336921Summary
ALFUZOSIN
Uroxatral, Xatral
Calculi
L_9795ALF-STONEEudraCT: 2005-005481-36Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted